TruTag Technologies and Spinnaker Biosciences Partner on a New Targeted, Controlled Release Therapy for Age-Related Macular Degeneration
EMERYVILLE, CA AND SOLANA BEACH, CA, December 20, 2023 — TruTag Technologies, Inc. and Spinnaker Biosciences, Inc. today announced that they have entered into a strategic supply partnership for TruTag’s advanced nano-porous silica (pSi) particles to support the commercialization of Spinnaker’s new therapy for the treatment of age-related macular degeneration (AMD). The Spinnaker therapy is […]